Back

Key immune related genes and potential therapeutic targets in immune checkpoint inhibitor associated myocarditis: a new fing

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Refining risk scores in cardio-oncology Organisation of a Cardio-Oncology Service ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Junyi Zhang

The Fourth Affiliated Hospital of Soochow University, Suzhou (China)

5 More presentations in this session

Presentation thumbnail
Efficacy and safety of prolonged edoxaban treatment for gastrointestinal cancer patients with isolated distal deep vein thrombosis: insight from the ONCO DVT study
Doctor Y. Yamashita (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Predictive factors and baseline risk stratification for CAR-T cell therapy-related cardiovascular toxicity
Professor D. Farmakis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization
Mr T. Caller (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
A novel machine learning-based adverse cardiovascular events risk score for cancer patients treated with immune checkpoint inhibitors
Mr J. Cross (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Myocardial fibrosis identification in patients with anthracycline-induced cardiotoxicity: a biomarkers and cardiac magnetic resonance correlation
Doctor R. Maragna (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Refining risk scores in cardio-oncology
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Heart failure hospitalization and outcomes in cancer patients undergoing immune checkpoint inhibitor treatment: a systematic review and meta-analysis
thumbnail
Congress Presentation
Cardiovascular adverse events in primary lung cancer patients treated with immune checkpoint inhibitors: a nationwide database study
thumbnail
Congress Presentation
Prognostic value of neutrophil-to-lymphocyte ratio and cardiac troponin I in patients with immune checkpoint inhibitors-related myocarditis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources